Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01928420 · ClinicalTrials.gov registry record · Phase 2
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease
A Phase 2 study, sponsored by Humanetics Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT01928420: Completed Phase 2 study, sponsored by Humanetics Corporation.
NCT01928420 is a Phase 2 study that has completed, run by Humanetics Corporation. The registered enrollment target is 30 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01928420, a Phase 2 study, has completed, sponsored by Humanetics Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of NIC5-15 in the treatment of Alzheimer's Disease.
Primary Outcome
A psychometric instrument that evaluates memory, attention, reasoning, language, orientation, and praxis.
Interventions
- DRUG Placebo
- DRUG Drug: NIC5-15
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-04 |
| Est. Completion | 2014-06 |
| Phase | Phase 2 |
What the finished NCT01928420 record still lists
NCT01928420 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01928420 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01928420 about?
NCT01928420 is a clinical study titled "A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease". The purpose of this study is to evaluate the safety and efficacy of NIC5-15 in the treatment of Alzheimer's Disease.
What is the current status of trial NCT01928420?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2007-04. Estimated completion is 2014-06.
What interventions are being tested in trial NCT01928420?
The interventions under investigation include: Placebo (DRUG), Drug: NIC5-15 (DRUG).
Who is sponsoring clinical trial NCT01928420?
This trial is sponsored by Humanetics Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01928420's enrollment target sits among peer trials
30 1582nd of 2000 higher than 332 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia